Glenn A. Oclassen, President and CEO at Transcept Pharmaceuticals Inc (TSPT), bought 30,000 shares at $2.82 ($85K) on 2011-08-10, disclosed to the SEC on 2011-08-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.82 | 27,833 | $78K | 92.8% |
| 2 | $2.82 | 2,167 | $6K | 7.2% |
| Total | $2.82 avg | 30,000 | $85K | 100% |
| Filing → |